Clinical Trial Update: A Randomized Trial of Udenafil Therapy in Patients With Heart Failure With Preserved Ejection Fraction [ULTIMATE-HFpEF] [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial is evaluating udenafil therapy for heart failure with preserved ejection fraction; the current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• udenafil (udenafil)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Diastolic Heart Failure | Phase 3 | Status: UNKNOWN